Recovery from serious fungal infections should be realisable for everyone (Q40107620)

17 September 2017

title

Recovery from serious fungal infections should be realisable for everyone (English)

1 reference

17 September 2017

David W Denning

0 references

Juan Luis Rodríguez Tudela

series ordinal

1 reference

17 September 2017

publication date

31 July 2017

1 reference

Lancet Infectious Diseases

17 September 2017

published in

1 reference

Hidden killers: human fungal infections

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Effect of fluconazole prophylaxis on fungal blood cultures: an autopsy-based study involving 720 patients with haematological malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Comparison of premortem clinical diagnoses in critically iII patients and subsequent autopsy findings

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Diagnostic errors in the intensive care unit: a systematic review of autopsy studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Global access to antifungal therapy and its variable cost.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

AIDS-related mycoses: the way forward

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Fungal infections in HIV/AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Candida and invasive mould diseases in non-neutropenic critically ill patients and patients with haematological cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Emerging issues, challenges, and changing epidemiology of fungal disease outbreaks

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Aspergillus fumigatus during stable state and exacerbations of COPD.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Pulmonary and sinus fungal diseases in non-immunocompromised patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Neglected endemic mycoses.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

The global problem of antifungal resistance: prevalence, mechanisms, and management

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Immunotherapeutic approaches to treatment of fungal diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Improvement of fungal disease identification and management: combined health systems and public health approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

Calling upon all public health mycologists : To accompany the country burden papers from 14 countries.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2817%2930319-5

7 January 2021

10.1016/S1473-3099(17)30319-5

Identifiers

DOI

1 reference

release_ijzmajbvgfhj3ficqr35qqgjne

17 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/ijzmajbvgfhj3ficqr35qqgjne

24 November 2022

mapped directly with Wikidata item

1 reference